Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
AIDS Research Consortium of Atlanta
mi
from
Atlanta, GA
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Updated: 1/1/1970
AIDS Research Consortium of Atlanta
mi
from
Atlanta, GA
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Neurology Specialists of Decatur Research Center
mi
from
Decatur, GA
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Updated: 1/1/1970
Neurology Specialists of Decatur Research Center
mi
from
Decatur, GA
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Updated: 1/1/1970
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Johns Hopkins University
mi
from
Baltimore, MD
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Updated: 1/1/1970
Johns Hopkins University
mi
from
Baltimore, MD
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
University of Toledo Medical Center
mi
from
Toledo, OH
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Updated: 1/1/1970
University of Toledo Medical Center
mi
from
Toledo, OH
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Amelia Court HIV Research Clinic
mi
from
Dallas, TX
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
Status: Archived
Updated: 1/1/1970
Amelia Court HIV Research Clinic
mi
from
Dallas, TX
Clinical 15 Months Study Comparing Monthly Pulse ACTH (Acthar Gel) Therapy With Monthly Methylprednisolone (MP, Solumedrol) for Multiple Sclerosis (MS) Patients Who Are on Regular Beta-interferons (Avonex, Betaseron or Rebif)
Comparison of Monthly Pulse ACTH (Acthar Gel) Therapy With Methylprednisolone (MP, Solumedrol) for Long-Term Treatment of Multiple Sclerosis (MS) as an Add on Therapy to Beta-interferons (Avonex, Betaseron or Rebif)
Status: Archived
Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Clinical 15 Months Study Comparing Monthly Pulse ACTH (Acthar Gel) Therapy With Monthly Methylprednisolone (MP, Solumedrol) for Multiple Sclerosis (MS) Patients Who Are on Regular Beta-interferons (Avonex, Betaseron or Rebif)
Comparison of Monthly Pulse ACTH (Acthar Gel) Therapy With Methylprednisolone (MP, Solumedrol) for Long-Term Treatment of Multiple Sclerosis (MS) as an Add on Therapy to Beta-interferons (Avonex, Betaseron or Rebif)
Status: Archived
Updated: 1/1/1970
Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Clinical Trial Facility
mi
from
Denver, CO
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Denver, CO
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Clinical Trial Facility
mi
from
Celebration, FL
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Celebration, FL
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Clinical Trial Facility
mi
from
Atlanta, GA
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Atlanta, GA
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Clinical Trial Facility
mi
from
Centralia, IL
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Centralia, IL
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Clinical Trial Facility
mi
from
Jeffersonville, IN
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Jeffersonville, IN
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Clinical Trial Facility
mi
from
Boston, MA
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Boston, MA
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Clinical Trial Facility
mi
from
Albany, NY
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albany, NY
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Clinical Trial Facility
mi
from
Lima, OH
An Observational Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Lima, OH
SOLITAIREâ„¢ FR With the Intention For Thrombectomy (SWIFT) Study
SOLITAIREâ„¢ FR With the Intention For Thrombectomy (SWIFT) Study
Status: Archived
Oregon Stroke Center, OHSU
mi
from
Portland, OR
SOLITAIREâ„¢ FR With the Intention For Thrombectomy (SWIFT) Study
SOLITAIREâ„¢ FR With the Intention For Thrombectomy (SWIFT) Study
Status: Archived
Updated: 1/1/1970
Oregon Stroke Center, OHSU
mi
from
Portland, OR
SOLITAIREâ„¢ FR With the Intention For Thrombectomy (SWIFT) Study
SOLITAIREâ„¢ FR With the Intention For Thrombectomy (SWIFT) Study
Status: Archived
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
SOLITAIREâ„¢ FR With the Intention For Thrombectomy (SWIFT) Study
SOLITAIREâ„¢ FR With the Intention For Thrombectomy (SWIFT) Study
Status: Archived
Updated: 1/1/1970
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Interacting Together Everyday: Recovery After Childhood Traumatic Brain Injury (TBI) "I-InTERACT
An Online Intervention for Families of Young Children With TBI: I-InTERACT
Status: Archived
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Interacting Together Everyday: Recovery After Childhood Traumatic Brain Injury (TBI) "I-InTERACT
An Online Intervention for Families of Young Children With TBI: I-InTERACT
Status: Archived
Updated: 1/1/1970
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active-Controlled Study to Evaluate the Effects of Switching Therapy (Glatiramer Acetate or Interferon β-1a) to Natalizumab in Subjects With Relapsing Remitting Multiple Sclerosis
Status: Archived
Clinical Research Facility
mi
from
Birmingham, AL
Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
A Multicenter, Randomized, Rater-Blind, Parallel-Group, Active-Controlled Study to Evaluate the Effects of Switching Therapy (Glatiramer Acetate or Interferon β-1a) to Natalizumab in Subjects With Relapsing Remitting Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Birmingham, AL
Pilot of Acupuncture to Improve Quality of Life in Veterans With Traumatic Brain Injury (TBI) and Post-Traumatic Stress Disorder (PTSD)
Pilot of Acupuncture to Improve Quality of Life in Veterans With TBI and PTSD
Status: Archived
East Orange VA Medical Center Health Care System
mi
from
East Orange, NJ
Pilot of Acupuncture to Improve Quality of Life in Veterans With Traumatic Brain Injury (TBI) and Post-Traumatic Stress Disorder (PTSD)
Pilot of Acupuncture to Improve Quality of Life in Veterans With TBI and PTSD
Status: Archived
Updated: 1/1/1970
East Orange VA Medical Center Health Care System
mi
from
East Orange, NJ
A Comparison of Skin Prick Tests, Clinical Symptoms, and Nasal Challenge Using a New Mouse Extract
A Comparison of Skin Prick Tests, Clinical Symptoms and Nasal Challenge Using a New Mouse Extract
Status: Archived
Clinical Research Center at Vanderbilt University
mi
from
Nashville, TN
A Comparison of Skin Prick Tests, Clinical Symptoms, and Nasal Challenge Using a New Mouse Extract
A Comparison of Skin Prick Tests, Clinical Symptoms and Nasal Challenge Using a New Mouse Extract
Status: Archived
Updated: 1/1/1970
Clinical Research Center at Vanderbilt University
mi
from
Nashville, TN
Cardiac Outcome Measures in Children With Muscular Dystrophy
PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Cardiac Outcome Measures in Children With Muscular Dystrophy
PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Updated: 1/1/1970
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Cardiac Outcome Measures in Children With Muscular Dystrophy
PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Washington University
mi
from
St. Louis, MO
Cardiac Outcome Measures in Children With Muscular Dystrophy
PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
Cardiac Outcome Measures in Children With Muscular Dystrophy
PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
University of Pittsburgh
mi
from
Pittsburgh, PA
Cardiac Outcome Measures in Children With Muscular Dystrophy
PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Updated: 1/1/1970
University of Pittsburgh
mi
from
Pittsburgh, PA
Cardiac Outcome Measures in Children With Muscular Dystrophy
PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Texas Children's Hospital - Feigin Center
mi
from
Houston, TX
Cardiac Outcome Measures in Children With Muscular Dystrophy
PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Updated: 1/1/1970
Texas Children's Hospital - Feigin Center
mi
from
Houston, TX
Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
Electrophysiological Effects of Guanfacine Extended-Release (GXR) on Inhibitory Control in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Archived
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
Electrophysiological Effects of Guanfacine Extended-Release (GXR) on Inhibitory Control in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Status: Archived
Updated: 1/1/1970
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex
Status: Archived
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex
Status: Archived
Updated: 1/1/1970
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex
Status: Archived
Baylor School of Medicine
mi
from
Houston, TX
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex
Status: Archived
Updated: 1/1/1970
Baylor School of Medicine
mi
from
Houston, TX
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Denver, CO
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Denver, CO
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Evanston, IL
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Evanston, IL
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Ayer, MA
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Ayer, MA
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Detroit, MI
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Detroit, MI
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Asheville, NC
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Asheville, NC
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Bend, OR
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bend, OR
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Houston, TX
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Houston, TX
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Salt Lake City, UT
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Salt Lake City, UT
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Clinical Research Facility
mi
from
Beloit, WI
JCV Antibody Program (STRATIFY-1)
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Beloit, WI
Chronic Fatigue Syndrome
Use of Lisdexamfetamine Dimesylate in Treatment of Cognitive Impairment (Chronic Fatigue Syndrome): A Double Blind, Placebo Controlled Study
Status: Archived
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Chronic Fatigue Syndrome
Use of Lisdexamfetamine Dimesylate in Treatment of Cognitive Impairment (Chronic Fatigue Syndrome): A Double Blind, Placebo Controlled Study
Status: Archived
Updated: 1/1/1970
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Trial of a Secondary Stroke Prevention Program
Development of a Stroke Prevention Program for an Underserved Minority Community
Status: Archived
Veterans Affairs Medical Center - Lakeside Chicago
mi
from
Chicago, IL
Trial of a Secondary Stroke Prevention Program
Development of a Stroke Prevention Program for an Underserved Minority Community
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - Lakeside Chicago
mi
from
Chicago, IL
Training Executive, Attention and Motor Skills (TEAMS): Preliminary Studies
Training Executive, Attention and Motor Skills (TEAMS): Preliminary Studies
Status: Archived
Queens College, City University of New York
mi
from
Flushing, NY
Training Executive, Attention and Motor Skills (TEAMS): Preliminary Studies
Training Executive, Attention and Motor Skills (TEAMS): Preliminary Studies
Status: Archived
Updated: 1/1/1970
Queens College, City University of New York
mi
from
Flushing, NY
Cardiac Magnetic Resonance in Children With Muscular Dystrophy
PITT0110 - Cardiac Magnetic Resonance: A Parallel Protocol to Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Cardiac Magnetic Resonance in Children With Muscular Dystrophy
PITT0110 - Cardiac Magnetic Resonance: A Parallel Protocol to Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Updated: 1/1/1970
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Cardiac Magnetic Resonance in Children With Muscular Dystrophy
PITT0110 - Cardiac Magnetic Resonance: A Parallel Protocol to Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
University of Pittsburgh
mi
from
Pittsburgh, PA
Cardiac Magnetic Resonance in Children With Muscular Dystrophy
PITT0110 - Cardiac Magnetic Resonance: A Parallel Protocol to Cardiac Outcome Measures in Children With Muscular Dystrophy
Status: Archived
Updated: 1/1/1970
University of Pittsburgh
mi
from
Pittsburgh, PA
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Birmingham Clinical Site 136
mi
from
Birmingham, AL
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Birmingham Clinical Site 136
mi
from
Birmingham, AL
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Tucson Clinical Site 133
mi
from
Tucson, AZ
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Tucson Clinical Site 133
mi
from
Tucson, AZ
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Aurora Clinical Site 132
mi
from
Aurora, CO
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Aurora Clinical Site 132
mi
from
Aurora, CO
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Fort Collins Clinical Site 123
mi
from
Fort Collins, CO
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Fort Collins Clinical Site 123
mi
from
Fort Collins, CO
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Fairfield Clinical Site 110
mi
from
Fairfield, CT
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Fairfield Clinical Site 110
mi
from
Fairfield, CT